Fundz

LaNova Medicines raised $41 million in a series C round led by China Biopharmaceuticals to advance its clinical pipeline and expand its innovative discovery platforms.

PRIVATEOct 18, 2024

Amount Raised

$41 Million

Round Type

Series C

ShanghaiBiotechnologyHealth CareBiopharma

Investors

Pudong Venture CapitalZhangjiang HaohengQiming Venture PartnersShanghai Biomedical FundChina Biopharmaceuticals

Description

LaNova Medicines, a Shanghai-based biopharma company, has secured $41 million in its series C funding round. The financing was led by China Biopharmaceuticals, with participation from multiple investors.

Quick answer

LaNova Medicines raised $41 Million in a Series C round, dated October 18, 2024. Investors: Pudong Venture Capital, Zhangjiang Haoheng, Qiming Venture Partners, Shanghai Biomedical Fund and China Biopharmaceuticals. LaNova Medicines is based in Shanghai, Shanghai, China.

How much did LaNova Medicines raise?
LaNova Medicines raised $41 Million in a Series C round on October 18, 2024.
Who invested in LaNova Medicines?
Pudong Venture Capital, Zhangjiang Haoheng, Qiming Venture Partners, Shanghai Biomedical Fund and China Biopharmaceuticals are named as investors in this round.
What does LaNova Medicines do?
LaNova Medicines is a Shanghai-based biopharmaceutical company focused on developing innovative therapies.
Where is LaNova Medicines based and how big is it?
LaNova Medicines is based in Shanghai, Shanghai, China.
Who are the decision-makers at LaNova Medicines?
Fundz holds 2 contacts at LaNova Medicines. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biopharma and Biotechnology around the same time

Companies in the same sectors as LaNova Medicines that raised within 45 days of this round, from Fundz verified event records.

  • HCW Biologics raised $6.9M on November 20, 2024.
  • Adipo Therapeutics raised $4.7M (Seed) on November 19, 2024.
  • Tempero Bio raised $77M on October 30, 2024.
  • Ensho Therapeutics raised $5M on October 24, 2024.
  • Vicebio Ltd raised $100M (Series B) on September 23, 2024.
  • ONL Therapeutics raised $65M (Series D) on September 16, 2024.

Who to call at LaNova Medicines, and when

A new round usually means LaNova Medicines is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day LaNova Medicines raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at LaNova Medicines, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at LaNova Medicines. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

LaNova Medicines

Location

Shanghai, Shanghai, China

About

LaNova Medicines is a Shanghai-based biopharmaceutical company focused on developing innovative therapies. The company aims to advance its clinical pipeline and enhance its discovery platforms. It is actively involved in the biotechnology industry and seeks to address unmet medical needs. LaNova is committed to bringing new treatments to market through strategic funding and partnerships.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment LaNova Medicines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for LaNova Medicines's next move

See what Strategic adds

LaNova Medicines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.